National Bank of Canada FI Boosts Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

National Bank of Canada FI boosted its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 68.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 179,363 shares of the company's stock after purchasing an additional 73,072 shares during the period. National Bank of Canada FI owned about 0.08% of Bath & Body Works worth $8,026,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Front Row Advisors LLC acquired a new position in Bath & Body Works during the 3rd quarter worth about $25,000. Trust Co. of Vermont acquired a new stake in shares of Bath & Body Works in the 3rd quarter valued at about $27,000. Denali Advisors LLC bought a new position in Bath & Body Works in the 4th quarter valued at about $27,000. GAMMA Investing LLC purchased a new stake in Bath & Body Works in the 4th quarter valued at about $27,000. Finally, Turtle Creek Wealth Advisors LLC bought a new stake in shares of Bath & Body Works in the 4th quarter worth approximately $35,000. Institutional investors and hedge funds own 95.14% of the company's stock.

Insider Activity

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the firm's stock in a transaction that occurred on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.19% of the company's stock.

Bath & Body Works Stock Performance

Shares of BBWI stock traded down $1.01 during mid-day trading on Friday, reaching $47.55. 1,693,616 shares of the company's stock traded hands, compared to its average volume of 2,715,815. The firm has a market capitalization of $10.69 billion, a PE ratio of 12.61, a price-to-earnings-growth ratio of 1.49 and a beta of 1.89. Bath & Body Works, Inc. has a 12 month low of $27.30 and a 12 month high of $50.34. The firm has a 50 day moving average price of $46.13 and a two-hundred day moving average price of $41.48.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, February 29th. The company reported $2.06 EPS for the quarter, beating the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The firm had revenue of $2.91 billion for the quarter, compared to the consensus estimate of $2.84 billion. During the same period last year, the firm earned $1.86 EPS. The company's revenue was up .8% on a year-over-year basis. As a group, equities analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Wells Fargo & Company boosted their target price on Bath & Body Works from $42.00 to $48.00 and gave the company an "equal weight" rating in a research note on Wednesday, April 24th. The Goldman Sachs Group lifted their price objective on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a "buy" rating in a research note on Monday, March 4th. Evercore ISI increased their target price on Bath & Body Works from $30.00 to $45.00 and gave the stock an "in-line" rating in a research report on Friday, March 1st. Robert W. Baird lifted their price target on Bath & Body Works from $50.00 to $54.00 and gave the company an "outperform" rating in a research report on Friday, March 1st. Finally, BMO Capital Markets upped their target price on Bath & Body Works from $48.00 to $50.00 and gave the stock an "outperform" rating in a research note on Friday, March 1st. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $46.73.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.